Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Heart Rhythm. 2008 Aug;5(8):1210-2. doi: 10.1016/j.hrthm.2008.05.006. Epub 2008 May 15.

QT prolongation is an unreliable predictor of ventricular arrhythmia.

Author information

  • Department of Pharmacology, Katholieke Universiteit Leuven, Leuven, Belgium. Luc.Hondeghem@screenQT.com

Abstract

Not all drugs that prolong the QT interval are proarrhythmic, and absence of QT prolongation is no guarantee for lack of proarrhythmia. Thus, QT prolongation is an unreliable predictor of ventricular arrhythmia. Development of drugs based on the absence of QT prolongation may stop development of some of the safest agents (with respect to arrhythmias). Conversely, drug-induced shortening of the QT interval may facilitate reentry, which might have lethal consequences in vulnerable patients. If QT prolongation and QT shortening must be avoided, then the pharmaceutical industry faces a mission impossible. Cardiac safety is better evaluated in terms of lambda, TRIaD (Triangulation, Reverse use dependence, Instability, and Dispersion), and disturbances of automaticity.

PMID:
18675236
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Icon for Elsevier Science
    Loading ...
    Write to the Help Desk